50397-69-8

Basic information

• Product Name: Acetic acid, [(4-bromophenyl)thio]-, methyl ester
• CAS NO: 50397-69-8
• Molecular Formula: C9H9BrO2S
• Molecular Weight: 261.139
• Mol File: 50397-69-8.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: Acetic acid, [(4-bromophenyl)thio]-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Acetic acid, [(4-bromophenyl)thio]-, methyl ester(50397-69-8)
• EPA Substance Registry System: Acetic acid, [(4-bromophenyl)thio]-, methyl ester(50397-69-8)

Safety Data

• Hazardous Substances Data: 50397-69-8(Hazardous Substances Data)

Upstream product

• 104-95-0 (4-bromophenyl)thioanisole 
• 96-32-2 bromoacetic acid methyl ester 
• 934-71-4 1-bromo-4-(methylsulfinyl)benzene 
• 106-53-6 para-bromobenzenethiol 
• 96-34-4 methyl chloroacetate 
• 67-56-1 methanol 
• 3406-76-6 (4-bromophenylthio)acetic acid 
• 186581-53-3 diazomethane 

Downstream Products

• 3406-76-6 (4-bromophenylthio)acetic acid 
• 250736-42-6 5-bromobenzo[b]thiophen-3(2H)-one 1,1-dioxide 
• 53920-28-8 2-((4-bromophenyl)thio)acetyl chloride 
• 63216-02-4 methyl 2-((4-bromophenyl)thio)-2-(4-methoxyphenyl)acetate 
• 50397-65-4 methyl 2-((4-bromophenyl)sulfonyl)acetate 
• 63216-00-2 p-bromophenylsulfinylacetic acid methyl ester 

Relevant articles and documents

Sulfoxide Reduction/C(sp3)-S Metathesis Cascade in Ionic Liquid

A sulfoxide reduction/C-S bond metathesis cascade between sulfoxides and alkyl bromides has been developed to access high-value sulfides without the use of any catalysts or bases. In this cascade, classical Kornblum oxidation is employed to reduce sulfoxides with alkyl bromides in ionic liquid. This protocol features high functional tolerance, mild conditions, promising scalability, and sustainable solvents.

ACYCLIC CYANOETHYLPYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS

The instant invention provides compounds of formula I which are JAK inhibitors, and as such are useful for the treatment of JAK-mediated diseases such as rheumatoid arthritis, asthma, COPD and cancer.

Syntheses and in vitro evaluation of arylsulfone-based MMP inhibitors with heterocycle-derived zinc-binding groups (ZBGs)

Several classes of arylsulfone-based MMP-2/-9 inhibitors utilizing 6- to 8-membered heterocyclic rings as zinc-binding groups (ZBGs) have been synthesized and their enzyme inhibitory activities were evaluated. Although a number of 6- and 7-membered hetero